Insider: Evans John M. CEO - Beam Therapeutics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 986,667 | 105,188 | 1,091,855 |
| Value | $24,331,208.22 | $2,593,936.08 | $26,925,144.30 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/31/2026 | DDS | 25,000 | Direct | COM | $22.76 | $569,085.00 | 986,667 |
| 03/30/2026 | DDS | 25,000 | Direct | COM | $22.37 | $559,230.00 | 986,667 |
| 01/30/2026 | DDS | 22,094 | Direct | COM | $28.27 | $624,672.50 | 989,573 |
| 01/30/2026 | DDS | 2,906 | Direct | COM | $29.00 | $84,274.00 | 986,667 |
| 01/29/2026 | DDS | 16,333 | Direct | COM | $29.19 | $476,801.10 | 995,334 |
| 01/29/2026 | DDS | 8,667 | Direct | COM | $29.74 | $257,780.85 | 986,667 |
| 10/02/2025 | DDS | 25,000 | Direct | COM | $24.63 | $615,667.50 | 986,667 |
| 10/01/2025 | DDS | 25,000 | Direct | COM | $24.51 | $612,655.00 | 986,667 |
| 04/01/2025 | DDS | 30,663 | Direct | COM | $18.35 | $562,684.45 | 986,249 |
| 01/30/2025 | DDS | 29,800 | Direct | COM | $26.75 | $797,027.82 | 908,859 |
| 01/30/2025 | DDS | 200 | Direct | COM | $27.28 | $5,456.00 | 908,659 |
| 09/30/2024 | DDS | 60,000 | Direct | COM | $24.60 | $1,476,024.00 | 938,659 |
| 04/01/2024 | DDS | 18,102 | Direct | COM | $32.13 | $581,617.26 | 1,058,343 |
| 03/28/2024 | DDS | 60,000 | Direct | COM | $33.86 | $2,031,402.00 | 998,262 |
| 01/31/2024 | DDS | 60,000 | Direct | COM | $25.33 | $1,519,800.00 | 1,058,262 |
| 04/04/2023 | DDS | 6,493 | Direct | COM | $29.09 | $188,904.10 | 1,117,979 |
| 04/03/2023 | DDS | 5,161 | Direct | COM | $30.31 | $156,429.91 | 1,124,472 |
| 10/31/2022 | DDS | 11,756 | Direct | COM | $46.88 | $551,136.56 | 1,061,429 |
| 10/31/2022 | DDS | 7,768 | Direct | COM | $46.19 | $358,819.46 | 1,073,185 |
| 10/31/2022 | DDS | 7,567 | Direct | COM | $44.92 | $339,944.45 | 1,080,953 |
| 10/31/2022 | DDS | 2,909 | Direct | COM | $47.89 | $139,324.81 | 1,058,520 |
| 10/31/2022 | DDS | 8,235 | Indirect | COM | $46.91 | $386,339.26 | 105,188 |
| 10/31/2022 | DDS | 5,008 | Indirect | COM | $44.93 | $224,993.41 | 117,992 |
| 10/31/2022 | DDS | 2,188 | Indirect | COM | $47.91 | $104,836.49 | 103,000 |
| 10/31/2022 | DDS | 4,569 | Indirect | COM | $46.19 | $211,033.89 | 113,423 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research